Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation-Reference-Cited by-同舟云学术

Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation

Published:2017-11 Issue:11 Volume:16 Page:908-916
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Latourelle Jeanne C,Beste Michael T,Hadzi Tiffany C,Miller Robert E,Oppenheim Jacob N,Valko Matthew P,Wuest Diane M,Church Bruce W,Khalil Iya G,Hayete Boris,Venuto Charles S

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference43 articles.

1. Parkinson's disease;Kalia;Lancet,2015

2. Prioritized research recommendations from the National Institute of Neurological Disorders and Stroke Parkinson's Disease 2014 conference;Sieber;Ann Neurol,2014

3. Prognostic factors for the progression of Parkinson's disease: a systematic review;Post;Mov Disord,2007

4. Clinical evolution of Parkinson's disease and prognostic factors affecting motor progression: 9-year follow-up study;Reinoso;Eur J Neurol,2015

5. CSF β-amyloid 1-42 predicts progression to cognitive impairment in newly diagnosed Parkinson disease;Terrelonge;J Mol Neurosci,2016

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single center open-label clinical phase I trial (NEON trial);2024-09-06

2. Subthalamic DBS does not restore deficits in corticospinal suppression during movement preparation in Parkinson’s disease;Clinical Neurophysiology;2024-09

3. Association between striatal amyloid deposition and motor prognosis in Parkinson's disease;European Journal of Neurology;2024-07-21

4. Risk for Mortality in High versus Low Antiparkinsonian Therapy Dose During the First Year of Parkinson’s Disease: A Real-World Study;Advances in Therapy;2024-07-08

5. Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions;Nature Communications;2024-07-05